A significant advance in cancer investigation is arising with the use of VHH fragments to reactivate mutated p53. This crucial cancer inhibitor protein is frequently inactivated in several forms of cancer, leading https://friendlybookmark.com/story21819139/mini-antibodies-reactivate-tumor-suppressor-p53-the-new-pathway-for-tumor-treatment